Glaukos (GKOS) Return on Capital Employed (2015 - 2026)
Glaukos (GKOS) posted quarterly Return on Capital Employed of 24.03% for Q2 2026, down 1326.0% year-over-year from 1.96% in Q2 2025, and up 2.8% quarter-over-quarter from 24.72% in Q1 2026.
Glaukos (GKOS) Return on Capital Employed (2015 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Return on Capital Employed for 12 consecutive years, with 24.03% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed fell 1326.0% year-over-year to 24.03%; the TTM figure through Jun 2026 stood at 24.03% (down 1326.0% YoY), while the FY2025 annual figure was 23.97%, down 1010.0% from the prior year.
- Return on Capital Employed grew to 24.03% in Q2 2026 per GKOS's latest filing, from 24.72% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.13% in Q1 2022 and bottomed at 24.72% in Q1 2026.
- Historically, Return on Capital Employed has averaged 13.39% across 5 years, with a median of 13.75% in 2023.
- Annual changes were most pronounced in 2022 — Return on Capital Employed jumped 1106 bps — and 2026, when it sank 1326 bps.
- Glaukos' Return on Capital Employed stood at 8.82% in 2022, then tumbled by 68 bps to 14.78% in 2023, then gained by 5 bps to 13.98% in 2024, then slumped by 69 bps to 23.62% in 2025, then decreased by 2 bps to 24.03% in 2026.
- Business Quant data shows GKOS's Return on Capital Employed at 24.03% in Q2 2026, 24.72% in Q1 2026, and 23.62% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Glaukos | 10.79 Bn | 10.68 Bn | 151.59 Mn | -24.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.03% |
| Mar 31, 2026 | -24.72% |
| Dec 31, 2025 | -23.62% |
| Sep 30, 2025 | -9.76% |
| Jun 30, 2025 | -10.77% |
| Mar 31, 2025 | -11.53% |
| Dec 31, 2024 | -13.98% |
| Sep 30, 2024 | -15.54% |
| Jun 30, 2024 | -15.84% |
| Mar 31, 2024 | -15.59% |
| Dec 31, 2023 | -14.78% |
| Sep 30, 2023 | -13.98% |
| Jun 30, 2023 | -13.03% |
| Mar 31, 2023 | -13.52% |
| Dec 31, 2022 | -8.82% |
| Sep 30, 2022 | -6.93% |
| Jun 30, 2022 | -3.48% |
| Mar 31, 2022 | -1.13% |
| Dec 31, 2021 | -3.31% |
| Sep 30, 2021 | -2.66% |